Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Papatheodoridis

Showing results (101-110 of 138) with videos related to

Pageof 14
Sort By:
Gastroenterology|November 26, 2008
2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis BYun-Fan Liaw, Edward Gane, Nancy Leung, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2020
Global real-world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohortsAlessandra Mangia, Scott Milligan, Mandana Khalili, et al.
Reviews in Endocrine & Metabolic Disorders|May 6, 2026
Overcoming the barriers in the screening, diagnosis, and follow-up of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH)Roberto Vettor, Maria Letizia Petroni, Idit Dotan, et al.
Journal of Hepatology|December 19, 2015
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapyGeorge Papatheodoridis, George Dalekos, Vana Sypsa, et al.
Digestive Diseases and Sciences|March 22, 2021
Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD CohortGiorgos Bamias, Georgios Kokkotis, Michalis Gizis, et al.
Digestive Diseases and Sciences|October 17, 2018
Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 AnalysisSang Hoon Ahn, Patrick Marcellin, Xiaoli Ma, et al.
Digestive Diseases and Sciences|August 24, 2018
Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 AnalysisSang Hoon Ahn, Patrick Marcellin, Xiaoli Ma, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 6, 2026
Physician Perspectives on Hepatitis C Treatment During Pregnancy: A Multinational Multispecialty SurveyTatyana Kushner, Maria Buti, Mohamed El-Kassas, et al.
Journal of Gastroenterology and Hepatology|July 8, 2026
Chronic Viral Hepatitis With MASLD: Implications for Clinical and Patient-Reported OutcomesGeorge Papatheodoridis, Maria Buti, Yusuf Yilmaz, et al.
Chinese Medical Journal|February 27, 2023
Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry studyHuai Zhang, Rafael S Rios, Jerome Boursier, et al.
Pageof 14

Showing results (101-110 of 138) with videos related to

Sort By:
Pageof 14
Gastroenterology|November 26, 2008
2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis BYun-Fan Liaw, Edward Gane, Nancy Leung, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2020
Global real-world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohortsAlessandra Mangia, Scott Milligan, Mandana Khalili, et al.
Reviews in Endocrine & Metabolic Disorders|May 6, 2026
Overcoming the barriers in the screening, diagnosis, and follow-up of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH)Roberto Vettor, Maria Letizia Petroni, Idit Dotan, et al.
Journal of Hepatology|December 19, 2015
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapyGeorge Papatheodoridis, George Dalekos, Vana Sypsa, et al.
Digestive Diseases and Sciences|March 22, 2021
Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD CohortGiorgos Bamias, Georgios Kokkotis, Michalis Gizis, et al.
Digestive Diseases and Sciences|October 17, 2018
Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 AnalysisSang Hoon Ahn, Patrick Marcellin, Xiaoli Ma, et al.
Digestive Diseases and Sciences|August 24, 2018
Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 AnalysisSang Hoon Ahn, Patrick Marcellin, Xiaoli Ma, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 6, 2026
Physician Perspectives on Hepatitis C Treatment During Pregnancy: A Multinational Multispecialty SurveyTatyana Kushner, Maria Buti, Mohamed El-Kassas, et al.
Journal of Gastroenterology and Hepatology|July 8, 2026
Chronic Viral Hepatitis With MASLD: Implications for Clinical and Patient-Reported OutcomesGeorge Papatheodoridis, Maria Buti, Yusuf Yilmaz, et al.
Chinese Medical Journal|February 27, 2023
Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry studyHuai Zhang, Rafael S Rios, Jerome Boursier, et al.
Pageof 14